⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRAX News
Praxis Precision Medicines, Inc. Common Stock
WealthHawk Joins FSI's CoveredAdvisor Affinity Benefits Program, Bringing Money-in-Motion Intelligence to Independent Advisors
prnewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
Form 8-K
sec.gov
PRAX
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
globenewswire.com
PRAX
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
globenewswire.com
PRAX
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
PRAX
SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders
businesswire.com
PRAX
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
globenewswire.com
PRAX
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
globenewswire.com
PRAX